Ciprofloxacin vs Irbesartan
Ciprofloxacin vs Irbesartan: Overview
This comparison examines the pharmacological differences between Ciprofloxacin and Irbesartan.
Mechanism of Action
Ciprofloxacin: Inhibits bacterial DNA gyrase and topoisomerase IV.
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Pharmacokinetics
Half-life: Ciprofloxacin β 4 hours; Irbesartan β 11-15 hours.
Chemical Properties
Molecular Formula: Ciprofloxacin β C17H18FN3O3; Irbesartan β C25H28N6O.
Molecular Weight: Ciprofloxacin β 331.3460 g/mol; Irbesartan β 428.5320 g/mol.
Type: Ciprofloxacin β Small molecule; Irbesartan β Small molecule.